Global private equity and venture capital news and research

Posts Tagged ‘Atlas Venture’

28 September 2015

Atlas Venture-led consortium helps fund latest Replimune cancer research

lab-217041_1280 Early-stage investment firm Atlas Venture has headed a group of investors to successfully close a $30m financing round for Oxford-based cancer therapeutics firm Replimune.

10 August 2015

VC-backed JenaValve closes $26.5m Series C round

dollars cash money Venture capital-backed JenaValve Technology, a maker of transcatheter aortic valve repair solutions, has closed a $26.5m Series C financing round.

23 January 2015

Atlas, Benchmark sell 3V Transaction Services for €14.5m

download Payment services, risk management and IT Solutions provider SafeCharge has purchased venture capital-backed 3V Transaction Services in a €14.5m deal.

9 January 2015

NEA, Atlas among VC backers $35m Surface Oncology Series A

Opsona research lab Cancer immunotherapy business Surface Oncology has picked up $35m of Series A financing from a string of venture capital firms.

24 October 2014

Atlas leads $17m round in Quartet Medicine

biotech lab clinic research Venture capital firm Atlas Venture has led a $17m Series A financing in bio-tech company Quartet Medicine.

14 October 2014

Bicycle Therapeutics VC backers return for £20m financing round

Bicycle Therapeutics A string of venture capital firms have renewed their commitment to UK-based biotech business Bicycle Therapeutics through a £20m financing round.

3 October 2014

Atlas Venture to split tech and life sciences arms into two separate firms

dirt-crevice-1-1021430-m Early stage-focused Atlas Venture has announced it plans to break the 35-year-old firm into two independent investment houses next year to make its technology and life sciences arms separate.

26 August 2014

The Raine Group helps DraftKings raise $41m

baseball Fantasy sports website DraftKings has raised $41m in a Series C round led by The Raine Group.

19 June 2014

Polaris backs biopharmaceutical startup Navitor’s $23.5m Series A

navitor Biopharmaceutical company Navitor Pharmaceuticals has raised a $23.5m Series A round from venture capital backer.

17 April 2014

The Currency Cloud raises $10m Series B

payment_lrg Payments technology startup The Currency Cloud has secured $10m in a Series B round backed by its existing investors.

Page 1 of 212

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015